Manager, Commercial Analytics - (Hybrid - Acton, MA)

Job Summary

As the Manager, Commercial Analytics you will play a pivotal role in driving transformative commercial outcomes across global markets. You will leverage advanced analytics to deliver strategic insights, performance analysis, and market intelligence that shape executive decision making and commercial strategy across regions.

This role is ideal for an analytical thought partner and proactive strategist—someone who tailors insights to regional needs, fosters cross functional collaboration, and contributes to global commercial success through data driven decision-making.



Role Overview

At Insulet our mission is to improve the lives of people living with Diabetes. We do this through our amazing product, Omnipod. Want to put your true marketing skills to work and be part of establishing the Omnipod brand in the hearts and minds of consumers? Then join the Global Digital Marketing team! These days, customers increasingly expect experiences that are relevant, timely, and personalized. Regardless of what channel they are using to interact with us – whether it is on a computer, mobile, or some other device – we want to make sure we are meeting and surpassing expectations with interactions that are easy and delightful.

As the Manager, Commercial Analytics you will play a pivotal role in driving transformative commercial outcomes across global markets. You will leverage advanced analytics to deliver strategic insights, performance analysis, and market intelligence that shape executive decision making and commercial strategy across regions.

This role is ideal for an analytical thought partner and proactive strategist—someone who tailors insights to regional needs, fosters cross functional collaboration, and contributes to global commercial success through data driven decision-making.

Key Responsibilities

• Apply advanced analytics and statistical modeling to evaluate commercial performance across regions.
• Uncover underlying drivers, trends, risks, and barriers influencing business outcomes.
• Use predictive analytics, scenario planning, and forecasting to inform proactive commercial strategies.

• Generate region specific, actionable insights that accelerate decision making and drive commercial alignment.
• Translate complex data into intuitive narratives that enable stakeholders to take decisive action.

• Develop clear, concise, and compelling reports that highlight commercial performance, trends, KPIs, and business implications.
• Build scalable executive dashboards and visualizations to support strategic conversations and quarterly business reviews.

• Collaborate closely with Finance, Strategy, Operations, and other cross functional partners to ensure accuracy, consistency, and alignment across commercial reporting.
• Champion analytics across the organization by socializing insights using strong storytelling and visualization techniques.

Education & Experience

• Bachelor’s degree in Business, Commercial Analytics, Economics, or related field required; Master’s degree preferred.
• 8+ years of experience in analytics, strategy, or commercial operations—ideally within MedTech, Pharma, or other regulated industries.
• Experience supporting global or multi-region commercial teams strongly preferred.
• Proven proficiency with SQL, Python, Tableau, Power BI, or equivalent analytics and visualization tools.

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable and waterproof Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero finger sticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

Studies have demonstrated the clinical and lifestyle advantages of insulin pump therapy over multiple daily insulin injections (MDI). However, many people still choose MDI therapy largely due to the complexity, cost, and inconvenience of conventional pump technology. The Omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. By breaking down the barriers to insulin pump therapy, Insulet hopes to provide both a superior treatment option and life-long health benefits for people with insulin-requiring diabetes.

Insulet was founded in 2000 with the mission to improve the lives of people with diabetes and enable customers to enjoy simplicity, freedom, and healthier lives through innovative technology. The Company’s world headquarters and state-of-the-art automated manufacturing facility are located in Acton, Massachusetts with global offices in the U.K., France, Germany, Netherlands, Canada, Mexico, Australia, and the United Arab Emirates. Omnipod products are available in 24 countries around the world.

Insulet recently concluded its seventh consecutive year of 20% or more revenue growth, and more than doubled its intellectual property portfolio over the last year. Insulet is proud to be recognized as a 2022 Top Workplace USA; awarded Top Workplaces Cultural Excellence Award for remote work; recognized as a Great Place to Work® in four international locations in 2023; and ranked as one of America’s most responsible companies by Newsweek. For more information, visit: insulet.com and omnipod.com.

This position is eligible for hybrid working arrangements and requires on-site work from an Insulet office. 

 #LI-Hybrid

Working at Insulet Corporation | Top Workplaces

Additional Information: